Icon completes Verisome PhIII; Indian scientists make cancer nanoparticles;

> Icon Bioscience reported that its Verisome delivery platform for post-cataract surgery inflammation has completed a Phase III study. Release

> A team at the Indian Institute of Science has developed nanocapsules to deliver cancer drugs. More

Suggested Articles

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.

Australia's University of New South Wales and Uka Tarsadia University in India will join forces to explore contact lenses for ocular drug delivery.